Tablets",
"Empagliflozin + Metformin Hydrochloride Tablets" and/or
"Empagliflozin + Linagliptin Tablets" or any "generic
version" thereof ... Tablets", "Empagliflozin + Metformin
Hydrochloride Tablets" and/or "Empagliflozin +
Linagliptin Tablets" or any "generic version" thereof or in
::: Downloaded
Tablets",
"Empagliflozin + Metformin Hydrochloride Tablets" and/or
"Empagliflozin + Linagliptin Tablets" or any "generic
version" thereof ... Tablets", "Empagliflozin + Metformin
Hydrochloride Tablets" and/or "Empagliflozin +
Linagliptin Tablets" or any "generic version" thereof or in
::: Downloaded
Empagliflozin + Metformin
4
Hydrochloride Tablets" and/or "Empagliflozin
+ Linagliptin Tablets" or any "generic version"
thereof or in any combination with ... Tablets",
"Empagliflozin + Metformin Hydrochloride
Tablets" and/or "Empagliflozin + Linagliptin
Tablets" or any "generic version" thereof
F. Hoffmann-La Roche Ag & Anr. vs Natco Pharma Limited on 24 March, 2025
Fmc Corporation & Ors vs Natco Pharma Limited on 17 November, 2025
$~
* IN THE HIGH
respondent no. 2 in respect of a medicinal product called 'LINAGLIPTIN', an
anti-diabetic product (hereinafter 'the subject patent'). The subject ... date for the commercial launch of the petitioner's generic
'LINAGLIPTIN' product, i.e. 22nd February, 2022.
Signature Not Verified
Digitally Signed
date for the commercial launch of the petitioner's generic
'LINAGLIPTIN' product, i.e. 22nd February, 2022.
7. Subsequently, on 19th February
dinner
Inj. Human Insulin Glargine: 16 units at 10.00 p.m.
Tab. Linagliptin 5 mg once daily
The patient is also receiving regular wound dressings
Tablets",
"Empagliflozin + Metformin Hydrochloride
Tablets" and/or "Empagliflozin + Linagliptin
Tablets" or any "generic version" thereof including
4
Fixed ... Dose Combination of Empagliflozin +
Linagliptin Tablets or any produce sold under the
trade mark(s)/name(s) "GLYMAXBI" or any other
trade mark
Tablets", "Empagliflozin + Metformin
Hydrochloride Tablets" and/or "Empagliflozin +
Linagliptin 59 Tablets" or any "generic version" thereof
